Alex Goldberg

Maxim Integrated Products, Inc. (NASDAQ:MXIM) and Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Added to Equity Profile Report's NASDAQ Active Stock Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/10/2014 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Maxim Integrated Products, Inc. (NASDAQ:MXIM) and Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS).

Maxim Integrated Products, Inc. (NASDAQ:MXIM) a company that designs, develops, manufactures, and markets various linear and mixed-signal integrated circuits worldwide is currently up (+1.86%) on 2,072,170 shares traded after MAXIM INTEGRATED PRODUCTS INC Reported its Financials. Maxim Integrated Products, Inc. (NASDAQ:MXIM) is currently up (+14.76%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Maxim Integrated Products, Inc. (NASDAQ:MXIM)

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) a biopharmaceutical company that focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers is currently down (-4.42%) on 2,332,805 shares traded after SUNESIS PHARMACEUTICALS INC Filed SEC form 8-K, Other Events, Financial Statements and Exhibits. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) is currently down (-26.71%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com